| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.004 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.076 | 0.004 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.093 | 0.007 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.078 | 0.007 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.007 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.008 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.008 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.01 |